Tak Paul Peter 4
4 · Candel Therapeutics, Inc. · Filed Nov 28, 2023
Insider Transaction Report
Form 4
Tak Paul Peter
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2023-11-26+180,108→ 416,999 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. 50% of the RSUs shall vest on June 30, 2024, and the remaining 50% on December 31, 2024, in each case subject to the Reporting Person's continued service on such vesting date.